Patrick Archdeacon

1.7k citations

22 papers · 1.2k indexed · h-index 15

Impact in

Transplantation top 1%
- Renal Transplantation Outcomes and Treatments
Nephrology top 5%
- Dialysis and Renal Disease Management

Papers in ⓘ

Public Health, Environmental and Occupational Health 6
- Ethics in Clinical Research 3
Economics and Econometrics 5
- Health Systems, Economic Evaluations, Quality of Life 4

Co-authors: Christine Kaufmann (2 shared papers)Myles H. Akabas (2 shared papers)Arthur Karlin (1 shared paper)Renata Albrecht (4 shared papers)Jacob L. Meyer (3 shared papers)Tiffany Cook (1 shared paper)Carolyn Y. Neuland (3 shared papers)Ergun Velidedeoğlu (2 shared papers)
Journals: Clinical Trials (4 papers)Clinical Journal of the American Society of Nephrology (3 papers)American Journal of Transplantation (3 papers)Journal of the American Society of Nephrology (2 papers)Pharmacoepidemiology and Drug Safety (2 papers)
Partner nations: United States United Kingdom

In The Last Decade

Patrick Archdeacon

22 papers receiving 1.2k citations

Peers

Countries citing papers authored by Patrick Archdeacon

Since Specialization

Citations

This map shows the geographic impact of Patrick Archdeacon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Archdeacon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Archdeacon more than expected).

Fields of papers citing papers by Patrick Archdeacon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Archdeacon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Archdeacon. The network helps show where Patrick Archdeacon may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick Archdeacon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Archdeacon Line = papers co-authored together Patrick Archdeacon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the α subunit Neuron ·Myles H. Akabas, Christine Kaufmann, Patrick Archdeacon, Arthur Karlin	1994	371
2	Summary of FDA Antibody-Mediated Rejection Workshop American Journal of Transplantation ·Patrick Archdeacon, Marieta Chan, Carolyn Y. Neuland, Ergun Velidedeoğlu, Jacob L. Meyer, LaRee Tracy, M Cavaillé‐Coll, S Bala, Ana M Guerreiro Hernández, Renata Albrecht	2011	139
3	Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator. Journal of Biological Chemistry ·Myles H. Akabas, Christine Kaufmann, Tiffany Cook, Patrick Archdeacon	1994	133
4	Summary of FDA Workshop on Ischemia Reperfusion Injury in Kidney Transplantation American Journal of Transplantation ·M Cavaillé‐Coll, S Bala, Ergun Velidedeoğlu, Ana M Guerreiro Hernández, Patrick Archdeacon, G. González, Carolyn Y. Neuland, Jacob L. Meyer, Renata Albrecht	2013	111
5	Summary of the US FDA Approval of Belatacept American Journal of Transplantation ·Patrick Archdeacon, Caitlin Dixon, Ozlem Belen, Renata Albrecht, Jacob L. Meyer	2012	86
6	CKD as a Model for Improving Chronic Disease Care through Electronic Health Records Clinical Journal of the American Society of Nephrology ·Paul E. Drawz, Patrick Archdeacon, Clement J. McDonald, Neil R. Powe, Kimberly A. Smith, Jenna M. Norton, Desmond E. Williams, Uptal D. Patel, Andrew S. Narva	2015	47
7	Fostering Innovation, Advancing Patient Safety Clinical Journal of the American Society of Nephrology ·Patrick Archdeacon, Rachel Shaffer, Wolfgang C. Winkelmayer, Ronald J. Falk, Prabir Roy‐Chaudhury	2013	40
8	Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative Clinical Trials ·Karim A. Calis, Patrick Archdeacon, Raymond P. Bain, David L. DeMets, Miriam L. Donohue, M. Khair ElZarrad, Annemarie Forrest, J. D. McEachern, Michael Pencina, Jane Perlmutter, Roger Lewis	2017	38
9	Pharmacokinetic Assessment in Patients Receiving Continuous RRT Clinical Journal of the American Society of Nephrology ·Thomas D. Nolin, George R. Aronoff, William H. Fissell, Lokesh Jain, Rajnikanth Madabushi, Kellie S. Reynolds, Lei Zhang, Shiew Mei Huang, Rajnish Mehrotra, Michael F. Flessner, John K. Leypoldt, Jennifer Witcher, Issam Zineh, Patrick Archdeacon, Prabir Roy‐Chaudhury, Stuart L. Goldstein	2014	35
10	Sentinel Modular Program for Propensity Score–Matched Cohort Analyses Epidemiology ·Meijia Zhou, Shirley Wang, Charles E. Leonard, Joshua J. Gagne, Candace C. Fuller, Christian Hampp, Patrick Archdeacon, Sengwee Toh, Aarthi Iyer, Tiffany S. Woodworth, Elizabeth Cavagnaro, Catherine A. Panozzo, Sophia Axtman, Ryan M. Carnahan, Elizabeth A. Chrischilles, Sean Hennessy	2017	29
11	Electronic clinical laboratory test results data tables: lessons from Mini‐Sentinel Pharmacoepidemiology and Drug Safety ·Marsha A. Raebel, Kevin Haynes, Tiffany S. Woodworth, G. Saylor, Elizabeth Cavagnaro, Kara O. Coughlin, Lesley H. Curtis, Mark G. Weiner, Patrick Archdeacon, Jeffrey S. Brown	2014	29
12	Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug‐Adverse Event Association Clinical Pharmacology & Therapeutics ·JJ Gagne, Xiaopeng Han, Sean Hennessy, Leonard Ce, Elizabeth A. Chrischilles, Ryan M. Carnahan, SV Wang, Candace C. Fuller, Aarthi Iyer, Hannah Katcoff, TS Woodworth, Patrick Archdeacon, T. E. Meyer, Sebastian Schneeweiß, Sengwee Toh	2016	27
13	Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative Journal of the American Society of Nephrology ·Laura M. Dember, Patrick Archdeacon, Mahesh Krishnan, Eduardo Lacson, Shari M. Ling, Prabir Roy‐Chaudhury, Kimberly Smith, Michael F. Flessner	2016	25
14	Overcoming Barriers in Kidney Health—Forging a Platform for Innovation Journal of the American Society of Nephrology ·Peter G. Linde, Patrick Archdeacon, Matthew D. Breyer, Tod Ibrahim, Jula K. Inrig, Reshma Kewalramani, Celeste Castillo Lee, Carolyn Y. Neuland, Prabir Roy‐Chaudhury, James A. Sloand, Rachel Meyer, Kimberly Smith, Jennifer Snook, Melissa West, Ronald J. Falk	2016	23
15	The Clinical Trials Transformation Initiative: innovation through collaboration Nature Reviews Drug Discovery ·Pamela Tenaerts, Leanne K. Madre, Patrick Archdeacon, Robert M. Califf	2014	23
16	FDA-Catalyst—Using FDA’s Sentinel Initiative for large-scale pragmatic randomized trials: Approach and lessons learned during the planning phase of the first trial Clinical Trials ·Noelle M. Cocoros, Sean D. Pokorney, Kevin Haynes, Crystal Garcia, Hussein R. Al‐Khalidi, Sana M. Al‐Khatib, Patrick Archdeacon, Jennifer C. Goldsack, Thomas Harkins, Nancy D. Lin, David Martin, Debbe McCall, Vinit Nair, Lauren E. Parlett, Robert Temple, Cheryl N. McMahill‐Walraven, Christopher B. Granger, Richard Platt	2018	14
17	Understanding the functions and operations of data monitoring committees: Survey and focus group findings Clinical Trials ·Karim A. Calis, Patrick Archdeacon, Raymond P. Bain, Annemarie Forrest, Jane Perlmutter, David L. DeMets	2016	14
18	Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug Application Therapeutic Innovation & Regulatory Science ·Patrick Archdeacon, Cheryl Grandinetti, José María Guerrero Vega, David Balderson, Judith M. Kramer	2013	13
19	Bone Morphogenetic Protein 7 (BMP7): A Critical Role in Kidney Development and a Putative Modulator of Kidney Injury Advances in Chronic Kidney Disease ·Patrick Archdeacon, Randal K. Detwiler	2008	13
20	FDA Perspective Transplantation ·Joette M. Meyer, Patrick Archdeacon, Renata Albrecht	2013	7

About Patrick Archdeacon

Patrick Archdeacon is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics, Statistics and Probability, Nephrology and Transplantation, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (5 papers), Renal Transplantation Outcomes and Treatments (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Meta-analysis and systematic reviews (3 papers), Ethics in Clinical Research (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Transplantation (252 citations), Nephrology (178 citations), Cellular and Molecular Neuroscience (202 citations), Statistics and Probability (75 citations) and Molecular Biology (502 citations). Patrick Archdeacon has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Christine Kaufmann, Myles H. Akabas, Arthur Karlin, Renata Albrecht, Jacob L. Meyer, Tiffany Cook, Carolyn Y. Neuland, Ergun Velidedeoğlu, Ana M Guerreiro Hernández and M Cavaillé‐Coll. Their work appears in journals such as Clinical Trials, Clinical Journal of the American Society of Nephrology, American Journal of Transplantation, Journal of the American Society of Nephrology and Pharmacoepidemiology and Drug Safety.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact